CD56+monocytes and CD31+endothelial cells as blood markers of COVID-19 disease severity

被引：0
|
作者：
Dutt, Taru S. [1 ]
Lavergne, Stephanie M. [2 ]
Webb, Tracy L. [3 ]
Baxter, Bridget A. [2 ]
Stromberg, Sophia [4 ]
Berry, Kailey [5 ]
Tipton, Madison [6 ]
Dunn, Julie [7 ]
Tamayo, Marcela Henao [1 ]
Ryan, Elizabeth P. [2 ]
机构：
[1] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA
[2] Colorado State Univ, Dept Environm Radiol & Hlth Sci, Ft Collins, CO 80523 USA
[3] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA
[4] Colorado State Univ, Dept Food Sci & Human Nutr, Ft Collins, CO 80523 USA
[5] Dept Mol Cellular & Integrat Neurosci, Ft Collins, CO USA
[6] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA
[7] Univ Colorado Hlth, Med Ctr Rockies, Loveland, CO USA
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2021年 / 51卷
关键词：
Biomarkers; infectious disease; memory; viral infections; visualizing immune responses;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-1155
引用
收藏
页码：384 / 384
页数：1
相关论文
共 50 条
  • [1] Comprehensive Immune Profiling Reveals CD56+ Monocytes and CD31+ Endothelial Cells Are Increased in Severe COVID-19 Disease
    Dutt, Taru S.
    LaVergne, Stephanie M.
    Webb, Tracy L.
    Baxter, Bridget A.
    Stromberg, Sophia
    McFann, Kim
    Berry, Kailey
    Tipton, Madison
    Alnachoukati, Omar
    Zier, Linda
    Ebel, Greg
    Dunn, Julie
    Henao-Tamayo, Marcela
    Ryan, Elizabeth P.
    JOURNAL OF IMMUNOLOGY, 2022, 208 (03): : 685 - 696
  • [2] CD147-high classical monocytes: a cellular biomarker for COVID-19 disease severity and treatment response
    Teruaki Murakami
    Yuta Yamaguchi
    Saori Amiya
    Yuko Yoshimine
    Shinichiro Nameki
    Yasutaka Okita
    Yasuhiro Kato
    Haruhiko Hirata
    Yoshito Takeda
    Atsushi Kumanogoh
    Takayoshi Morita
    Inflammation and Regeneration, 45 (1)
  • [3] Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19
    Osburn, William O.
    Smith, Kimberly
    Yanek, Lisa
    Amat-Alcaron, Nuria
    Thiemann, David R.
    Cox, Andrea L.
    Leucker, Thorsten M.
    Lowenstein, Charles J.
    PLOS ONE, 2022, 17 (05):
  • [4] Alterations in the CD56- and CD56+ T Cell Subsets during COVID-19
    Vavilova, Julia D.
    Ustiuzhanina, Maria O.
    Boyko, Anna A.
    Streltsova, Maria A.
    Kust, Sofya A.
    Kanevskiy, Leonid M.
    Iskhakov, Rustam N.
    Sapozhnikov, Alexander M.
    Gubernatorova, Ekaterina O.
    Drutskaya, Marina S.
    Bychinin, Mikhail V.
    Novikova, Oksana N.
    Sotnikova, Anna G.
    Yusubalieva, Gaukhar M.
    Baklaushev, Vladimir P.
    Kovalenko, Elena I.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [5] Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients
    Campana, Stefania
    De Pasquale, Claudia
    Migliore, Giacomo Sidoti
    Pezzino, Gaetana
    Cavaliere, Riccardo
    Rullo, Emmanuele Venanzi
    Nunnari, Giuseppe
    Caramori, Gaetano
    David, Antonio
    Bonaccorsi, Irene
    Pollicino, Teresa
    Carrega, Paolo
    Ferlazzo, Guido
    JOURNAL OF IMMUNOLOGY, 2022, 209 (04): : 655 - 659
  • [6] CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity
    Jan-Moritz Doehn
    Christoph Tabeling
    Robert Biesen
    Jacopo Saccomanno
    Elena Madlung
    Eva Pappe
    Frieder Gabriel
    Florian Kurth
    Christian Meisel
    Victor M. Corman
    Leif G. Hanitsch
    Sascha Treskatsch
    Kathrin Heim
    Miriam S. Stegemann
    Christoph Ruwwe-Glösenkamp
    Holger C. Müller-Redetzky
    Alexander Uhrig
    Rajan Somasundaram
    Claudia Spies
    Horst von Bernuth
    Jörg Hofmann
    Christian Drosten
    Norbert Suttorp
    Martin Witzenrath
    Leif E. Sander
    Ralf-Harto Hübner
    Infection, 2021, 49 : 757 - 762
  • [7] CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity
    Doehn, Jan-Moritz
    Tabeling, Christoph
    Biesen, Robert
    Saccomanno, Jacopo
    Madlung, Elena
    Pappe, Eva
    Gabriel, Frieder
    Kurth, Florian
    Meisel, Christian
    Corman, Victor M.
    Hanitsch, Leif G.
    Treskatsch, Sascha
    Heim, Kathrin
    Stegemann, Miriam S.
    Ruwwe-Gloesenkamp, Christoph
    Mueller-Redetzky, Holger C.
    Uhrig, Alexander
    Somasundaram, Rajan
    Spies, Claudia
    von Bernuth, Horst
    Hofmann, Jorg
    Drosten, Christian
    Suttorp, Norbert
    Witzenrath, Martin
    Sander, Leif E.
    Huebner, Ralf-Harto
    INFECTION, 2021, 49 (04) : 757 - 762
  • [8] Alterations in CD39/CD73 axis of T cells associated with COVID-19 severity
    Dorneles, Gilson P.
    Teixeira, Paula C.
    da Silva, Igor M.
    Schipper, Lucas L.
    Santana Filho, Paulo C.
    Rodrigues Junior, Luiz C.
    Bonorino, Cristina
    Peres, Alessandra
    Fonseca, Simone G.
    Monteiro, Marta C.
    Boeck, Carina R.
    Eller, Sarah
    Oliveira, Tiago F.
    Wendland, Eliana M.
    Romao, Pedro R. T.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (08) : 3394 - 3407
  • [9] Phenylalanine and COVID-19: Tracking disease severity markers
    Luporini, Rafael Luis
    Pott-Junior, Henrique
    Leal, Maria Carolina B. Di Medeiros
    Castro, Alex
    Ferreira, Antonio Gilberto
    Cominetti, Marcia Regina
    Anibal, Fernanda de Freitas
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
  • [10] Human embryonic stem cells demonstrate that mpl expression initially appears on a population of CD31+endothelial cells with hemogenic potential
    Kamata, T
    Gong, YP
    Wang, SH
    Leavitt, AD
    BLOOD, 2005, 106 (11) : 1008A - 1008A
12345